Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fate Therapeutics Inc (NASDAQ:FATE)

6.65
Delayed Data
As of 3:59pm ET
 +0.04 / +0.61%
Today’s Change
3.50
Today|||52-Week Range
8.78
+32.21%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close6.61
Today’s open6.71
Day’s range6.55 - 6.83
Volume100,719
Average volume (3 months)123,950
Market cap$189.7M
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+64.12%
Earnings growth (this year)-5.51%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book4.80

Competitors

 Today’s
change
Today’s
% change
VSTMVerastem Inc+0.69+14.05%
SZYMSolazyme Inc+0.15+6.73%
ENZYEnzymotec Ltd+0.12+1.32%
ONVOOrganovo Holdings In...+0.19+8.23%
Data as of 4:00pm ET, 08/27/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$0.00
Annual profit (last year)-$25.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christian Weyer
Chief Financial &
Operating Officer
J. Scott Wolchko
Corporate headquarters
San Diego, California

Forecasts

Partner Offers